Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
Amazon
AMZN
|
+$1.62B |
| 2 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
+$412M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$352M |
| 4 |
Vanguard World Funds Extended Duration ETF
EDV
|
+$286M |
| 5 |
Vanguard Total Bond Market
BND
|
+$246M |
Top Sells
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$511M |
| 2 |
T-Mobile US
TMUS
|
+$349M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$246M |
| 4 |
Utilities Select Sector SPDR Fund
XLU
|
+$240M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$229M |
Sector Composition
| 1 | Consumer Discretionary | 17.88% |
| 2 | Technology | 11% |
| 3 | Healthcare | 5.31% |
| 4 | Communication Services | 4.68% |
| 5 | Financials | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMC
3526
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $63K | ﹤0.01% |
3,075
-3,460
| -53% | -$70.9K |
|
|
NH
3527
DELISTED
NantHealth, Inc
NH
| $62K | ﹤0.01% |
1,754
-2,027
| -54% | -$71.7K |
|
|
AMBO
3528
Ambow Education Holding
AMBO
$10.5M
| $61K | ﹤0.01% |
+1,216
| New | +$61K |
|
|
ERF
3529
DELISTED
Enerplus Corporation
ERF
| $61K | ﹤0.01% |
32,628
-57,253
| -64% | -$107K |
|
3530
Comscore
SCOR
$34.1M
| $60K | ﹤0.01% |
1,485
+680
| +84% | +$27.5K |
|
3531
BGC Group
BGC
$4.82B
| $58K | ﹤0.01% |
24,168
-285,994
| -92% | -$686K |
|
3532
Marchex
MCHX
$86.6M
| $58K | ﹤0.01% |
27,471
-160,584
| -85% | -$339K |
|
3533
NanoViricides
NNVC
$23.3M
| $58K | ﹤0.01% |
+15,196
| New | +$58K |
|
3534
ProQR Therapeutics
PRQR
$231M
| $58K | ﹤0.01% |
+12,012
| New | +$58K |
|
|
ACR
3535
ACRES Commercial Realty
ACR
$154M
| $57K | ﹤0.01% |
9,119
-67,336
| -88% | -$421K |
|
3536
Curis
CRIS
$22.7M
| $57K | ﹤0.01% |
+2,419
| New | +$57K |
|
3537
Harrow
HROW
$1.46B
| $57K | ﹤0.01% |
10,191
-34,892
| -77% | -$195K |
|
3538
Protalix BioTherapeutics
PLX
$144M
| $57K | ﹤0.01% |
14,661
-129,160
| -90% | -$502K |
|
3539
TherapeuticsMD
TXMD
$12.8M
| $56K | ﹤0.01% |
712
-2,080
| -74% | -$164K |
|
|
ORBC
3540
DELISTED
ORBCOMM, Inc.
ORBC
| $56K | ﹤0.01% |
+16,539
| New | +$56K |
|
3541
TETRA Technologies
TTI
$630M
| $55K | ﹤0.01% |
108,461
-1,056,072
| -91% | -$536K |
|
|
ENZ
3542
DELISTED
Enzo Biochem, Inc.
ENZ
| $55K | ﹤0.01% |
+25,915
| New | +$55K |
|
|
GRU
3543
DELISTED
ELEMENTS Linked to the ICE BofAML Commodity Index eXtra Grains Total Return
GRU
| $55K | ﹤0.01% |
18,293
+7,873
| +76% | +$23.7K |
|
|
APTS
3544
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $55K | ﹤0.01% |
+10,095
| New | +$55K |
|
|
MIN
3545
MFS Intermediate Income Trust
MIN
$307M
| $54K | ﹤0.01% |
14,576
-25,085
| -63% | -$92.9K |
|
3546
Prospect Capital
PSEC
$1.29B
| $54K | ﹤0.01% |
+10,805
| New | +$54K |
|
3547
Arbutus Biopharma
ABUS
$855M
| $53K | ﹤0.01% |
16,825
-89,356
| -84% | -$281K |
|
3548
Broadwind
BWEN
$51.6M
| $53K | ﹤0.01% |
18,475
+6,082
| +49% | +$17.4K |
|
|
CPE
3549
DELISTED
Callon Petroleum Company
CPE
| $52K | ﹤0.01% |
10,745
-262,287
| -96% | -$1.27M |
|
|
CALA
3550
DELISTED
Calithera Biosciences, Inc
CALA
| $52K | ﹤0.01% |
+753
| New | +$52K |
|